XM does not provide services to residents of the United States of America.
I
I

IDEX

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Idex Corporation Announces Pricing Of Public Offering Of Senior Notes

BRIEF-Idex Corporation Announces Pricing Of Public Offering Of Senior Notes Aug 7 (Reuters) - IDEX Corp IEX.N : IDEX CORPORATION ANNOUNCES PRICING OF PUBLIC OFFERING OF SENIOR NOTES IDEX CORP - PRICES PUBLIC OFFERING OF $500M SENIOR NOTES Source text for Eikon: ID:nBw8SK5K2a Further company coverage: IEX.N
I

IDEX Corp reports results for the quarter ended in June - Earnings Summary

IDEX Corp reports results for the quarter ended in June - Earnings Summary IDEX Corp IEX.N reported quarterly adjusted earnings of $2.06​​ per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of $2.18. The mean expectation of twelve analysts for the quarter was for earnings of $2.04 per share.
I

IDEX Corp cuts 2024 profit view on slowing demand for industrial equipment

IDEX Corp cuts 2024 profit view on slowing demand for industrial equipment July 31 (Reuters) - Industrial equipment maker IDEX Corp IEX.N lowered its 2024 profit forecast on Wednesday as demand for industrial machinery and tools fell, sending its shares down nearly 5% after the bell. U.S. manufacturing activity contracted for a third straight month in June, as high borrowing rates and sticky inflation prompted companies to limit their expenses.
I

Idex Reports Second Quarter Results And Updates 2024 Outlook

BRIEF-Idex Reports Second Quarter Results And Updates 2024 Outlook July 31 (Reuters) - IDEX Corp IEX.N : IDEX REPORTS SECOND QUARTER RESULTS AND UPDATES 2024 OUTLOOK Q3 ORGANIC SALES ARE PROJECTED TO BE 0% TO 1% OVER PRIOR YEAR PERIOD SEES FULL YEAR GAAP DILUTED EPS OF $6.85 - $6.95, ADJUSTED DILUTED EPS OF $7.80 - $7.90 SEES Q3 GAAP DILUTED EPS OF
I

IDEX Q2 Adjusted EPS USD 2.06 Vs. IBES Estimate USD 2.04

BRIEF-IDEX Q2 Adjusted EPS USD 2.06 Vs. IBES Estimate USD 2.04 Jul 31 (Reuters) - IDEX Q2 adjusted net income USD 156.1 million vs. IBES estimate USD 152.4 million. Q2 adjusted EBITDA USD 224.2 million Q2 sales USD 807.2 million vs. IBES estimate USD 827.8 million
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.